Commit To Buy Cellular Biomedicine Group At $15, Earn 17.9% Annualized Using Options
April 29, 2016 at 11:35 AM EDT
Investors eyeing a purchase of Cellular Biomedicine Group Inc (CBMG) shares, but tentative about paying the going market price of $17.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $15 strike, which has a bid at the time of this writing of $1.70..